Sarcopenia Treatments Market - Global Outlook and Forecast 2022-2028

January 2022 | 72 pages | ID: SC222C24A0EFEN
Market Monitor Global

Abstracts

Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.

This report contains market size and forecasts of Sarcopenia Treatments in Global, including the following market information:

Global Sarcopenia Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sarcopenia Treatments market was valued at 2842.8 million in 2021 and is projected to reach US$ 3843.4 million by 2028, at a CAGR of 4.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Protein Supplement Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sarcopenia Treatments include Abbott Laboratories, Nestl?, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sarcopenia Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sarcopenia Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sarcopenia Treatments Market Segment Percentages, by Type, 2021 (%)

• Protein Supplement
• Calcium Supplement
• Other

Global Sarcopenia Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sarcopenia Treatments Market Segment Percentages, by Application, 2021 (%)

• Online Pharmacies
• Retail Pharmacies

Global Sarcopenia Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sarcopenia Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sarcopenia Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sarcopenia Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Nestl?
• Pfizer
• Amway
• By-health
• Usana
• A&Z Pharmaceutical
• GlaxoSmithKline
• Bayer
• H&H
• Blackmores
• Zhendong Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sarcopenia Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sarcopenia Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SARCOPENIA TREATMENTS OVERALL MARKET SIZE

2.1 Global Sarcopenia Treatments Market Size: 2021 VS 2028
2.2 Global Sarcopenia Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sarcopenia Treatments Players in Global Market
3.2 Top Global Sarcopenia Treatments Companies Ranked by Revenue
3.3 Global Sarcopenia Treatments Revenue by Companies
3.4 Top 3 and Top 5 Sarcopenia Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sarcopenia Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sarcopenia Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Sarcopenia Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sarcopenia Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sarcopenia Treatments Market Size Markets, 2021 & 2028
  4.1.2 Protein Supplement
  4.1.3 Calcium Supplement
  4.1.4 Other
4.2 By Type - Global Sarcopenia Treatments Revenue & Forecasts
  4.2.1 By Type - Global Sarcopenia Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Sarcopenia Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Sarcopenia Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sarcopenia Treatments Market Size, 2021 & 2028
  5.1.2 Online Pharmacies
  5.1.3 Retail Pharmacies
5.2 By Application - Global Sarcopenia Treatments Revenue & Forecasts
  5.2.1 By Application - Global Sarcopenia Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Sarcopenia Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Sarcopenia Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sarcopenia Treatments Market Size, 2021 & 2028
6.2 By Region - Global Sarcopenia Treatments Revenue & Forecasts
  6.2.1 By Region - Global Sarcopenia Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Sarcopenia Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Sarcopenia Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sarcopenia Treatments Revenue, 2017-2028
  6.3.2 US Sarcopenia Treatments Market Size, 2017-2028
  6.3.3 Canada Sarcopenia Treatments Market Size, 2017-2028
  6.3.4 Mexico Sarcopenia Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sarcopenia Treatments Revenue, 2017-2028
  6.4.2 Germany Sarcopenia Treatments Market Size, 2017-2028
  6.4.3 France Sarcopenia Treatments Market Size, 2017-2028
  6.4.4 U.K. Sarcopenia Treatments Market Size, 2017-2028
  6.4.5 Italy Sarcopenia Treatments Market Size, 2017-2028
  6.4.6 Russia Sarcopenia Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Sarcopenia Treatments Market Size, 2017-2028
  6.4.8 Benelux Sarcopenia Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sarcopenia Treatments Revenue, 2017-2028
  6.5.2 China Sarcopenia Treatments Market Size, 2017-2028
  6.5.3 Japan Sarcopenia Treatments Market Size, 2017-2028
  6.5.4 South Korea Sarcopenia Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Sarcopenia Treatments Market Size, 2017-2028
  6.5.6 India Sarcopenia Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sarcopenia Treatments Revenue, 2017-2028
  6.6.2 Brazil Sarcopenia Treatments Market Size, 2017-2028
  6.6.3 Argentina Sarcopenia Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sarcopenia Treatments Revenue, 2017-2028
  6.7.2 Turkey Sarcopenia Treatments Market Size, 2017-2028
  6.7.3 Israel Sarcopenia Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Sarcopenia Treatments Market Size, 2017-2028
  6.7.5 UAE Sarcopenia Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Sarcopenia Treatments Major Product Offerings
  7.1.4 Abbott Laboratories Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Nestl?
  7.2.1 Nestl? Corporate Summary
  7.2.2 Nestl? Business Overview
  7.2.3 Nestl? Sarcopenia Treatments Major Product Offerings
  7.2.4 Nestl? Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.2.5 Nestl? Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Sarcopenia Treatments Major Product Offerings
  7.3.4 Pfizer Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Amway
  7.4.1 Amway Corporate Summary
  7.4.2 Amway Business Overview
  7.4.3 Amway Sarcopenia Treatments Major Product Offerings
  7.4.4 Amway Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.4.5 Amway Key News
7.5 By-health
  7.5.1 By-health Corporate Summary
  7.5.2 By-health Business Overview
  7.5.3 By-health Sarcopenia Treatments Major Product Offerings
  7.5.4 By-health Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.5.5 By-health Key News
7.6 Usana
  7.6.1 Usana Corporate Summary
  7.6.2 Usana Business Overview
  7.6.3 Usana Sarcopenia Treatments Major Product Offerings
  7.6.4 Usana Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.6.5 Usana Key News
7.7 A&Z Pharmaceutical
  7.7.1 A&Z Pharmaceutical Corporate Summary
  7.7.2 A&Z Pharmaceutical Business Overview
  7.7.3 A&Z Pharmaceutical Sarcopenia Treatments Major Product Offerings
  7.7.4 A&Z Pharmaceutical Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.7.5 A&Z Pharmaceutical Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Sarcopenia Treatments Major Product Offerings
  7.8.4 GlaxoSmithKline Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 Bayer
  7.9.1 Bayer Corporate Summary
  7.9.2 Bayer Business Overview
  7.9.3 Bayer Sarcopenia Treatments Major Product Offerings
  7.9.4 Bayer Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.9.5 Bayer Key News
7.10 H&H
  7.10.1 H&H Corporate Summary
  7.10.2 H&H Business Overview
  7.10.3 H&H Sarcopenia Treatments Major Product Offerings
  7.10.4 H&H Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.10.5 H&H Key News
7.11 Blackmores
  7.11.1 Blackmores Corporate Summary
  7.11.2 Blackmores Business Overview
  7.11.3 Blackmores Sarcopenia Treatments Major Product Offerings
  7.11.4 Blackmores Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.11.5 Blackmores Key News
7.12 Zhendong Group
  7.12.1 Zhendong Group Corporate Summary
  7.12.2 Zhendong Group Business Overview
  7.12.3 Zhendong Group Sarcopenia Treatments Major Product Offerings
  7.12.4 Zhendong Group Sarcopenia Treatments Revenue in Global Market (2017-2022)
  7.12.5 Zhendong Group Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sarcopenia Treatments Market Opportunities & Trends in Global Market
Table 2. Sarcopenia Treatments Market Drivers in Global Market
Table 3. Sarcopenia Treatments Market Restraints in Global Market
Table 4. Key Players of Sarcopenia Treatments in Global Market
Table 5. Top Sarcopenia Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sarcopenia Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sarcopenia Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sarcopenia Treatments Product Type
Table 9. List of Global Tier 1 Sarcopenia Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sarcopenia Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sarcopenia Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sarcopenia Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sarcopenia Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sarcopenia Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sarcopenia Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sarcopenia Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sarcopenia Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sarcopenia Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sarcopenia Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sarcopenia Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sarcopenia Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sarcopenia Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sarcopenia Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sarcopenia Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sarcopenia Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sarcopenia Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sarcopenia Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sarcopenia Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sarcopenia Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Sarcopenia Treatments Product Offerings
Table 32. Abbott Laboratories Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Nestl? Corporate Summary
Table 34. Nestl? Sarcopenia Treatments Product Offerings
Table 35. Nestl? Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Sarcopenia Treatments Product Offerings
Table 38. Pfizer Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Amway Corporate Summary
Table 40. Amway Sarcopenia Treatments Product Offerings
Table 41. Amway Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 42. By-health Corporate Summary
Table 43. By-health Sarcopenia Treatments Product Offerings
Table 44. By-health Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 45. Usana Corporate Summary
Table 46. Usana Sarcopenia Treatments Product Offerings
Table 47. Usana Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 48. A&Z Pharmaceutical Corporate Summary
Table 49. A&Z Pharmaceutical Sarcopenia Treatments Product Offerings
Table 50. A&Z Pharmaceutical Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Sarcopenia Treatments Product Offerings
Table 53. GlaxoSmithKline Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Sarcopenia Treatments Product Offerings
Table 56. Bayer Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 57. H&H Corporate Summary
Table 58. H&H Sarcopenia Treatments Product Offerings
Table 59. H&H Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 60. Blackmores Corporate Summary
Table 61. Blackmores Sarcopenia Treatments Product Offerings
Table 62. Blackmores Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)
Table 63. Zhendong Group Corporate Summary
Table 64. Zhendong Group Sarcopenia Treatments Product Offerings
Table 65. Zhendong Group Sarcopenia Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sarcopenia Treatments Segment by Type in 2021
Figure 2. Sarcopenia Treatments Segment by Application in 2021
Figure 3. Global Sarcopenia Treatments Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Sarcopenia Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sarcopenia Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sarcopenia Treatments Revenue in 2021
Figure 8. By Type - Global Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 12. US Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 24. China Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sarcopenia Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sarcopenia Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Nestl? Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amway Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. By-health Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Usana Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. A&Z Pharmaceutical Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. H&H Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Blackmores Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Zhendong Group Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)